On the 25th June, the Cochrane Review was released - a study searching 11,000 publications and 16,000 samples to evaluate the functionality of antibody testing for the coronavirus. But the data is not as conclusive as you might think - and my own study of 411 long haulers, along with fresh pre-print studies from teaching hospitals in the UK draw a very different picture. These antibody tests are not as effective as their manufacturers would have you believe. But why?
0:00 Introduction
0:26 The Issue
1:36 The Cochrane Review
7:30 Hypothesis
9:40 The Long Haulers Study
16:17 Conclusion
References:
MEDIA:
BMJ: Cochrane Review:
[ Ссылка ]
Reuters
[ Ссылка ]
Prof. Jon Deeks tweet thread:
[ Ссылка ]
Science Daily - Robust evidence for CFS:
[ Ссылка ]
The Guardian, Debbie Bogaert
[ Ссылка ]
STUDIES:
Cochrane Review:
[ Ссылка ]
[ Ссылка ]
University Hospitals Birmingham / Richter et al - healthcare workers:
[ Ссылка ]
UCLH Sapphire study / Bampoe et al - Ob/Gyn hospital study:
[ Ссылка ]
Long et al: Asymptomatic vs Symptomatic:
[ Ссылка ]
Interfamilial study, Gallais et al:
[ Ссылка ]
Robust T Cell Immunity, Sekine et al (Sweden)
[ Ссылка ]
Systemic mucosal study, Cervia et al (Switzerland)
[ Ссылка ]
Preprint - Spike Protein
[ Ссылка ]
[ Ссылка ]
